Effect of epoetin alfa therapy on cognitive function in anaemic patients with solid tumours undergoing chemotherapy
Author:
Publisher
Wiley
Subject
Oncology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2354.2007.00857.x/fullpdf
Reference32 articles.
1. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology;Aaronson;Journal of the National Cancer Institute,1993
2. Prevention of anemia in patients with solid tumors receiving platinum-based chemotherapy by recombinant human erythropoietin (rHuEpo): a prospective, open label, randomized trial by the Hellenic Cooperative Oncology Group;Bamias;Oncology,2003
3. Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients;Bohlius;Journal of the National Cancer Institute,2006
4. EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer;Bokemeyer;European Journal of Cancer,2004
5. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury;Brines;Proceedings of the National Academy of Sciences of the United States of America,2000
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Blood-based biomarkers of cancer-related cognitive impairment in non-central nervous system cancer: A scoping review;Critical Reviews in Oncology/Hematology;2022-12
2. Four decades of chemotherapy-induced cognitive dysfunction: comprehensive review of clinical, animal and in vitro studies, and insights of key initiating events;Archives of Toxicology;2021-11-02
3. Cancer-related cognitive impairment in patients with non-central nervous system malignancies: an overview for oncology providers from the MASCC Neurological Complications Study Group;Supportive Care in Cancer;2020-11-24
4. Chemotherapy-induced cognitive impairment (CICI): An overview of etiology and pathogenesis;Life Sciences;2020-10
5. Pharmacologic management of cognitive impairment induced by cancer therapy;The Lancet Oncology;2019-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3